Venkatesan Jay
Serina Therapeutics, Inc. · Director
Venkatesan Jay is listed in filings as Director at Serina Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 21, 2026, including purchase activity. Recent filings connect the profile to Serina Therapeutics, Inc. (SER) and Elicio Therapeutics, Inc. (ELTX). The current snapshot covers public activity from Jul 2, 2024 to Apr 21, 2026. Reported amounts are shown as $14.7K to $46.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $250k50k shares | BuyJun 28, 2024 | $5.00 | $3.11 | |
| $50050k shares | BuyJun 28, 2024 | $0.01 | $3.11 |